Poster Abstract Session:
237. HIV/HCV Coinfection and Liver Disease
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Tracks: Trainee, Pediatric ID, HIV-STD-TB, Adult ID

Presentations:
Factors Associated with Delay in Therapy for Chronic Hepatitis C
Donald Rice Jr., MD ; Michelle Ordoveza, MD ; Ann Palmer, MD ; George Wu, MD ; Lisa M. Chirch, MD
The Care Cascade of Hepatitis C Management with Direct-Acting Antivirals in HIV-Infected Individuals
Lemuel Non, MD ; Jimmy Ma, MD ; Surachai Amornsawadwattana, MD ; Alexandria Garavaglia-Wilson, PharmD ; Rachel Presti, MD, PhD
Posters
  • IDWeekPoster.pdf (38.3 kB)
  • HCV Treatment Outcomes in HIV-HCV Co-infected Patients at an Urban, Academic, Health System.
    Manish Patel, PharmD ; Saira Rab, PharmD ; Aley Kalapila, MD ; Alison Kyle, NP ; Lesley Miller, MD
    The Natural History of FIB-4 Score Progression among HIV/HCV co-infected Adults in an Outpatient Clinic
    Bianca Yuh, BS ; Onyema Ogbuagu, MD, FACP ; Merceditas Villanueva, MD
    Lack of Interaction Between Elbasvir/Grazoprevir and Approved HIV and HBV Drugs in Viral Replication In Vitro.
    Robert Chase, MA ; Stephanie Curry, MS ; Min Xu, PhD ; Lei Ba, MS ; Carolyn Bahnck-Teets, MS ; Frederick Lahser, PhD ; Steve Carroll, PhD ; Ernest Asante-Appiah, PhD
    A Cohort of Spanish Coinfected HIV/HVC Prisoners Treated with Direct Acting Antiviral Agents (DAAs).
    Paloma Gijón, MD/PhD ; Ana Álvarez-Uría, MD ; Elena Reigadas, Pharm/PhD ; Teresa Aldámiz, MD/PhD ; Oihane Aldecoa-Otarola, MD ; Francisco Fernandez-González, MD/PhD
    Posters
  • Slide1.PNG (3.9 MB)
  • HCV Treatment Failure in HIV Co-Infected Patient
    Joan Duggan, MD, FIDSA, FACP ; Eric Sahloff, PharmD, AAHIVP
    High burden of AIDS defining conditions and increased mortality with hepatitis coinfection in HIV-infected adults in an inner city Medical Intensive Care Unit
    Eric Miller, MD ; Carl Nieweld, MD ; Michelle Doll, MD, MPH ; Kapil Saharia, MD, MPH ; Ulrike Buchwald, MD, Dr. med
    Analysis of HIV/HCV Co-infection and Mortality across Cohorts of HIV+ Patients in Middle Tennessee
    Ekta Nayyar, MD MS ; Cathy Jenkins, MS ; Todd Hulgan, MD, MPH, FIDSA ; Sally Bebawy, BS ; Megan Turner, M.A ; Joanna Shaw, MD ; Siddharth Pratap, Ph.D. ; Mohammad Tabatabai, Ph.D. ; Timothy R. Sterling, MD, FIDSA ; Vladimir Berthaud, MD MPH
    Hepatitis C (HCV) Treatment Experience with Direct Acting Antivirals (DAAs) in a Large Urban Clinic
    Sonia Vibhakar, PharmD ; Oluwatoyin Adeyemi, MD ; Rebecca Goldberg, RN ; Kerianne Burke, MPH ; Maureen Gallagher, NP ; Deborah Wolen, NP ; Benjamin Go, MD ; Gregory Huhn, MD, MPHTM
    Risk of Acute Liver Injury with Modern Antiretroviral Therapy
    Charitha Gowda, MD ; Craig W. Newcomb, MS ; Qing Liu, MD ; Dena M. Carbonari, MS ; James D. Lewis, MD, MSCE ; Kimberly Forde, MD, MHS ; David S. Goldberg, MD, MSCE ; K. Rajender Reddy, MD ; Jason Roy, PhD ; Amy R. Marks, MPH ; Jennifer L. Schneider, MPH ; Jay R. Kostman, MD ; Douglas Corley, MD, PhD ; Janet P. Tate, ScD ; Amy C. Justice, MD, PhD ; Vincent Lo Re III, MD, MSCE
    Posters
  • ARV_ALI_IDWeek Poster #2157.pdf (591.1 kB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.